Among the cytokines driven by mutational KRAS activation, we show that mutant KRAS causes a substantial increase in CSF2 production in several CRC cell lines, and that CSF2 is indispensable for the functional activation of TAMs. The gene discussed is CSF2; the disease is colorectal carcinoma.